Breaking News: Ebola

Filters close
Newswise:Video Embedded covid-19-a-wake-up-call-for-the-need-for-new-antiviral-weapons
VIDEO
Released: 26-May-2020 3:00 PM EDT
COVID-19: A wake-up call for the need for new antiviral weapons
Morgridge Institute for Research

Even after heroic medical and societal efforts finally break the back of the current COVID-19 pandemic, the global sigh of relief may not last long. The chilling reality is that viral threats are growing more common. And they’re getting deadlier.

Released: 7-May-2020 6:30 PM EDT
Dearth of Medical Resources in Africa for COVID-19 Reminiscent of Early HIV/AIDS Pandemic
Georgetown University Medical Center

Global health scholars have issued a clarion call about the needless loss of life expected because of a foreseeable prospect of “slow and inadequate access to supplies” to control COVID-19 in sub-Saharan Africa. They say what is unfolding now is similar to when lifesaving diagnostics and treatments came to the region long after they were available elsewhere.

Released: 21-Apr-2020 1:15 PM EDT
The PALM Trial honored with the Society for Clinical Trials’ prestigious David Sackett Trial of the Year Award for 2020
Society for Clinical Trials

Each year since 2008, SCT has awarded the David Sackett Trial of the Year Award to a randomized, controlled trial published (either electronically or in print) in the previous calendar year. The 2020 recipient is Pamoja Tulinde Maisha (PALM [“Together Save Lives”] in the Kiswahili language) trial.

Newswise: UCLA clinical trial tests anti-viral drug remdesivir and other therapies against COVID-19
Released: 3-Apr-2020 4:25 PM EDT
UCLA clinical trial tests anti-viral drug remdesivir and other therapies against COVID-19
University of California, Los Angeles (UCLA), Health Sciences

UCLA Health is one of 75 sites around the globe participating in a clinical trial sponsored by the National Institutes of Health to test the effectiveness of a candidate anti-viral drug against COVID-19.

Newswise: mask-fear-uc-santa-barbara-current.jpg?itok=6q-lFuIQ
Released: 19-Mar-2020 1:55 PM EDT
Pandemic Panic
University of California, Santa Barbara

After the Ebola virus tore through western Africa in 2015, two UC Santa Barbara researchers studied the xenophobia of the disease generated among people who had almost zero chance of being infected by it.

Released: 2-Mar-2020 2:15 PM EST
Study reveals how drug meant for Ebola may also work against coronaviruses
University of Alberta

A group of University of Alberta researchers who have discovered why the drug remdesivir is effective in treating the coronaviruses that cause Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS) expect it might also be effective for treating patients infected with the new COVID-19 strain.

Released: 27-Feb-2020 1:50 PM EST
How door-to-door canvassing slowed an epidemic
Massachusetts Institute of Technology (MIT)

Liberia was the epicenter of a high-profile Ebola outbreak in 2014-15, which led to more than 10,000 deaths in West Africa.

Newswise: When coronavirus is not alone
21-Feb-2020 12:05 PM EST
When coronavirus is not alone
University of Vermont

Interacting contagious diseases like influenza and pneumonia—and perhaps coronavirus too—follow the same complex spreading patterns as social trends, like the adoption of new slang or technologies. This new finding, published in Nature Physics, could lead to better tracking and intervention when multiple diseases spread through a population at the same time.

Newswise: Researchers Show How Ebola Virus Hijacks Host Lipids
12-Feb-2020 12:30 PM EST
Researchers Show How Ebola Virus Hijacks Host Lipids
Biophysical Society

Robert Stahelin studies some of the world’s deadliest viruses. Filoviruses, including Ebola virus and Marburg virus, cause viral hemorrhagic fever with high fatality rates. Stahelin, professor at Purdue University, examines how these viruses take advantage of human host cells.

Newswise: 223895_web.jpg
Released: 12-Feb-2020 3:10 PM EST
Coronavirus outbreak raises question: Why are bat viruses so deadly?
University of California, Berkeley

It's no coincidence that some of the worst viral disease outbreaks in recent years -- SARS, MERS, Ebola, Marburg and likely the newly arrived 2019-nCoV virus -- originated in bats.

Newswise: A Fast and Inexpensive Device to Capture and Identify Viruses
20-Dec-2019 12:55 PM EST
A Fast and Inexpensive Device to Capture and Identify Viruses
Penn State Materials Research Institute

A device to quickly capture and identify various strains of virus has been developed, according to researchers at Penn State and New York University.

Newswise: Research at Argonne's Advanced Photon Source leads to new Ebola drug
Released: 9-Dec-2019 2:45 PM EST
Research at Argonne's Advanced Photon Source leads to new Ebola drug
Argonne National Laboratory

Scientists using specialized beamlines at Argonne's Structural Biology Center (SBC), a facility for macromolecular crystallography at the Advanced Photon Source, derived insights that led to the discovery of a promising new drug for Ebola.

Newswise: La Jolla Institute for Immunology acquires Berkeley Lights Beacon® platform
Released: 9-Dec-2019 1:00 AM EST
La Jolla Institute for Immunology acquires Berkeley Lights Beacon® platform
La Jolla Institute for Immunology

La Jolla Institute for Immunology (LJI) is placing their confidence in Berkeley Lights’ Beacon® Optofluidic Platform and B cell antibody discovery workflow to accelerate the discovery of rare and lifesaving antibodies for the treatment of re-emerging and emerging diseases.

Newswise: Texas Biomed continues testing Ebola therapies and vaccines showing promise in outbreak areas
Released: 26-Sep-2019 12:05 PM EDT
Texas Biomed continues testing Ebola therapies and vaccines showing promise in outbreak areas
Texas Biomedical Research Institute

In mid-August 2019, human clinical trials were halted in the current Ebola epidemic that has claimed more than 2,100 lives in Africa. The findings resulted in the discontinuation of two of the drugs in the trial. Future patients will be randomly assigned to receive either REGN-EB3 (Regeneron) or mAb114 (Ridgeback Biotherapeutics) in an extension phase of the study. Texas Biomedical Research Institute scientists in the Institute’s Biosafety Level 4 contract research program conducted preclinical testing of several of the compounds in the trial, working with Regeneron and the Biomedical Advanced Research and Development Authority (BARDA).

Newswise: Community-Based Wildlife Carcass Surveillance Is Key for Early Detection of Ebola Virus
Released: 28-Aug-2019 1:05 PM EDT
Community-Based Wildlife Carcass Surveillance Is Key for Early Detection of Ebola Virus
Wildlife Conservation Society

WCS (Wildlife Conservation Society) and NIH (National Institutes of Health) scientists partnered with the Republic of Congo Ministry of Health to develop a low-cost educational outreach program and surveillance system for wildlife mortality that has continued now for over a decade.

Newswise: Machine Learning Helps Create Detailed, Efficient Models of Water
Released: 9-Aug-2019 3:05 PM EDT
Machine Learning Helps Create Detailed, Efficient Models of Water
Department of Energy, Office of Science

A team devised a way to better model water’s properties. They developed a machine-learning workflow that offers accurate and computationally efficient models.

Released: 8-Aug-2019 3:05 PM EDT
Existing anti-parasitic drug could offer treatment for Ebola
Boston Children's Hospital

Amid the worsening Ebola outbreak in the Congo, now threatening to spill into Rwanda, a new study suggests that an existing, FDA-approved drug called nitazoxanide could potentially help contain this deadly

Released: 18-Jul-2019 1:05 PM EDT
Declaration of PHEIC in DRC Should Spur Support, Not Fear
Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA)

The World Health Organization’s declaration today that the year-long Ebola crisis is a Public Health Emergency of International Concern is hoped to raise much-needed awareness and resources for preparedness and control efforts across the region. The decision was made following new incidents highlighting risks of repeated cross-border spread of the ongoing Ebola outbreak in the Democratic Republic of Congo.

Newswise: uganda-transmission.jpg
Released: 25-Jun-2019 8:50 AM EDT
New Transmission Model for Ebola Predicted Latest Uganda Cases
Kansas State University

A new risk assessment model for the transmission of Ebola accurately predicted its spread into the Republic of Uganda, according to the Kansas State University researchers who developed it. They published "Risk assessment of Ebola virus disease spreading in Uganda using a multilayer temporal network" in bioRxiv before the Uganda cases.

Released: 29-May-2019 3:05 PM EDT
Ebola Crisis in DRC Demands Immediate, Ongoing Investments
Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA)

The Ebola outbreak in the Democratic Republic of Congo’s North Kivu province remains uncontrolled despite heroic efforts on the part of international and local responders. The spread of the disease continues to pose imminent risks of cross-border transmission. In its 11th month, the outbreak has claimed nearly 1,300 lives.

Newswise: NIH awards $35 million grant to establish global Consortium to develop treatments for Ebola, Lassa and other viral threats
27-May-2019 12:05 PM EDT
NIH awards $35 million grant to establish global Consortium to develop treatments for Ebola, Lassa and other viral threats
La Jolla Institute for Immunology

La Jolla Institute Professor Erica Ollmann Saphire, Ph.D., will lead a five-year global effort totaling up to $35 million that brings together experts from around the world to streamline and accelerate the development of immunotherapeutics against emerging and re-emerging viral threats. The international consortium is funded through the Centers of Excellence for Translational Research (CETR) program at the National Institute of Allergy and Infectious Disease), part of the National Institutes of Health (NIH).

Newswise: Kansas State University zoonotic disease research fights viruses in the hot zone
Released: 23-May-2019 12:05 PM EDT
Kansas State University zoonotic disease research fights viruses in the hot zone
Kansas State University

Kansas State University researchers are helping battle most of the nation's top-priority zoonotic diseases.

Released: 21-May-2019 10:05 AM EDT
Positive Aspects of Masculinity Helps Improve Boys’ Attitudes Toward Relationship Violence
Rutgers University-New Brunswick

A program aimed at reducing violence against women and girls by focusing on positive expressions of masculinity changed the attitudes of middle school boys who may have been prone to harassment and dating violence as they got older, according to a Rutgers University–New Brunswick and University of New Hampshire led study that was done in partnership with prevention practitioners in New England.

Newswise:Video Embedded vaccines-for-everyone
VIDEO
Released: 21-May-2019 8:05 AM EDT
Vaccines for everyone
McMaster University

Researchers at McMaster University have invented a stable, affordable way to store fragile vaccines for weeks at a time at temperatures up to 40C, opening the way for life-saving anti-viral vaccines to reach remote and impoverished regions of the world.

Released: 7-May-2019 12:50 PM EDT
Groundbreaking Study Could Lead to Fast, Simple Test for Ebola Virus
Loyola Medicine

In a breakthrough that could lead to a simple and inexpensive test for Ebola virus disease, researchers have generated two antibodies to the deadly virus. The antibodies, which are inexpensive to produce, potentially could be used in a simple filter paper test to detect Ebola virus and the related Marburg virus.

Released: 24-Apr-2019 1:05 PM EDT
Newly discovered Ebolavirus may not cause severe disease in humans
University of Kent

Researchers from the University of Kent's School of Biosciences have provided evidence that a newly discovered Ebolavirus may not be as deadly as other species to humans.

Newswise: Ebola Virus – Subject Matter Experts
Released: 12-Apr-2019 2:30 PM EDT
Ebola Virus – Subject Matter Experts
Georgetown University Medical Center

Georgetown University faculty offer expertise for journalists seeking interviews in a variety of subjects related to Ebola. Topics include WHO, Public Health Emergency of International Concern (PHEIC), International Health Regulations, infectious disease control and treatment, vaccine development, clinical trials, and global health security and law.

Newswise: New $22 Million Project Targets Deadly Viruses
Released: 3-Apr-2019 3:05 PM EDT
New $22 Million Project Targets Deadly Viruses
Albert Einstein College of Medicine

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.

Newswise: Robots Without Borders: Finding new ways to treat Ebola
AUDIO
Released: 4-Mar-2019 9:00 AM EST
Robots Without Borders: Finding new ways to treat Ebola
Oregon State University, College of Engineering

Aid workers put their lives on the line to treat patients with Ebola. Can robots help make their jobs a little easier and allow more people to survive the disease? Bill Smart, professor of robotics at Oregon State University, is exploring how robots may be most useful during disease outbreaks.

Newswise: Sophisticated Blood Analysis Provides New Clues About Ebola, Treatment Avenues
6-Feb-2019 5:15 PM EST
Sophisticated Blood Analysis Provides New Clues About Ebola, Treatment Avenues
Pacific Northwest National Laboratory

A detailed analysis of blood samples from Ebola patients is providing clues about the progression of the effects of the virus in patients and potential treatment pathways. The findings point to a critical role for a molecular pathway that relies on the common nutrient choline, as well as the importance of cellular bodies known as microvesicles.

Newswise:Video Embedded scientists-wage-fight-against-aging-bone-marrow-stem-cell-niche-study-suggests-restoring-body-s-blood-factory-to-boost-immunity-fend-off-cancers-cincinnati-as-people-get-older-so-do-the-hematopoietic-stem-cells-hscs-that-form-their-blood-creating-an-incre
VIDEO
Released: 28-Jan-2019 9:05 AM EST
NIAID-Sponsored Clinical Trial of Ebola Vaccines Begins at Cincinnati Children's
Cincinnati Children's Hospital Medical Center

A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) has begun in the United States at Cincinnati Children’s Hospital Medical Center. The study is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID).

Newswise: Another Piece of Ebola Virus Puzzle Identified
Released: 17-Jan-2019 10:00 AM EST
Another Piece of Ebola Virus Puzzle Identified
Texas Biomedical Research Institute

A team of researchers have discovered the interaction between an Ebola virus protein and a protein in human cells that may be an important key to unlocking the pathway of replication of the killer disease in human hosts. Scientists at Texas Biomedical Research Institute were part of a nationwide collaborative with scientists at Gladstone Institutes, UC San Francisco and Georgia State University for a study recently published in the journal Cell.

Released: 13-Dec-2018 11:05 AM EST
Ebola-Fighting Protein Discovered in Human Cells
Northwestern University

Ebola virus (green) infects human cells much more easily when you remove the protective RBBP6 protein (compare left to right). Researchers have discovered a human protein that helps fight the Ebola virus and could one day lead to an effective therapy against the deadly disease, according to a new study from Northwestern University, Georgia State University, University of California, San Francisco (UCSF) and the Gladstone Institutes published today, Dec.

Newswise: Texas Biomed Scientists Researching Ebola-Malaria Connection
Released: 17-Oct-2018 11:00 AM EDT
Texas Biomed Scientists Researching Ebola-Malaria Connection
Texas Biomedical Research Institute

Texas Biomed researchers – in collaboration with the University of Iowa – are trying to find out how malarial infections impact people exposed to Ebola virus. Both diseases are endemic in that region.

10-Oct-2018 9:10 AM EDT
Synthetic DNA Vaccine Against Ebola Virus Shows Potent and Long-term Efficacy in Preclinical Studies
Wistar Institute

A novel synthetic DNA vaccine developed based on technology pioneered by Wistar scientists offers complete protection from Zaire Ebolavirus (EBOV) infection in promising preclinical research.

Newswise: Text Messages Quickly Track Health Care Use During Ebola Outbreak
27-Sep-2018 1:05 PM EDT
Text Messages Quickly Track Health Care Use During Ebola Outbreak
New York University

A new study from the NYU College of Global Public Health and NYU Tandon School of Engineering, published in Nature Digital Medicine, used text message surveys to determine in real time how people used maternal health services during a recent Ebola outbreak and measured a drop in hospital-based births during the outbreak.

Newswise: Rare Antibodies Show Scientists How to Neutralize the Many Types of Ebola
Released: 12-Sep-2018 4:45 PM EDT
Rare Antibodies Show Scientists How to Neutralize the Many Types of Ebola
Scripps Research Institute

Two new studies by scientists at Scripps Research are bringing Ebola virus’s weaknesses into the spotlight, showing for the first time exactly how human and mouse antibodies can bind to the virus and stop infection—not only for Ebola virus, but for other closely related pathogens as well.

Released: 24-Aug-2018 6:05 PM EDT
As Ebola outbreak spreads, a research team introduces new questions with the discovery of first known virus transmission from female survivor
Northern Arizona University

Geneticist Jason Ladner talks about the study, which underscores the need for focused prevention efforts among survivors and better capacity to detect new cases of the deadly virus.

Newswise: New Research Pinpoints Pathways Ebola Virus Uses to Enter Cells
Released: 8-Aug-2018 10:00 AM EDT
New Research Pinpoints Pathways Ebola Virus Uses to Enter Cells
Texas Biomedical Research Institute

A new study at Texas Biomedical Research Institute is shedding light on the role of specific proteins that trigger a mechanism allowing Ebola virus to enter cells to establish replication.

Released: 6-Aug-2018 10:05 AM EDT
Novel Vaccine Approach Proves Powerful Against Zika Virus
Ohio State University

A uniquely designed experimental vaccine against Zika virus has proven powerful in mice, new research has found.

Newswise: Ebola Virus - Subject Matter Experts
Released: 1-Aug-2018 2:05 PM EDT
Ebola Virus - Subject Matter Experts
Georgetown University Medical Center

WASHINGTON — Georgetown University professors offer expertise for journalists seeking interviews in a variety of subjects related to Ebola. Topics include infectious disease control and treatment, vaccine development, clinical trials, global health security, and international health regulations. To schedule an interview, please contact Karen Teber at km463@georgetown.


Showing results

150 of 273

close
2.12295